Figure 8

Cell viability of 3T3 NIH fibroblasts and MCF-7 breast cancer cells. Antiproliferative assays of (A) HO-AAVPA, (C) PAMAM-G4 and (E) HO-AAVP-PAMAM-G4 complex on 3T3 NIH fibroblasts and (B) HO-AAVPA, (D) PAMAM-G4, (F) HO-AAVP-PAMAM-G4 complex on MCF-7 breast cancer cells. All treatments were carry out for 48 h with n = 8 duplicate*** < 0.05; treatment versus control.